Article
Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin.
Pediatric blood & cancer - 1 Jul 2009
Watt Tanya, Warshaw Barry, Katzenstein Howard M
Abstract excerpt
Atypical hemolytic uremic syndrome remains a challenge to diagnose and treat, with significant acute morbidity and risk for progression to end stage renal disease. Treatment strategies center on plasma exchange but do not necessarily affect the progression of disease. We report the case of a patient with atypical HUS resulting from a mutation in the complement pathway who responded to treatment with steroids and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
